ArticleTranslational lung cancer research2022

Safety and efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients with preexisting antinuclear antibodies: a retrospective cohort study.

Dongming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.